Redmile Group, LLC
Top Portfolio Positions
35 positions ·
$1,984,563,976 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
18,133,242 | $891,430,176 | 44.92% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
673,505 | $173,979,811 | 8.77% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,164,120 | $135,583,747 | 6.83% | |
| IMNM |
Immunome Inc.
Healthcare
|
5,558,885 | $121,572,814 | 6.13% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
7,732,808 | $119,858,524 | 6.04% | |
| ANNX |
Annexon, Inc.
Healthcare
|
14,549,768 | $80,605,714 | 4.06% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
15,470,502 | $58,014,382 | 2.92% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
4,368,804 | $36,610,577 | 1.84% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
5,539,724 | $35,620,425 | 1.79% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
2,892,176 | $30,338,925 | 1.53% |
Portfolio Trend
25 quarters · across all stocks
Holdings in RGNX
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,610,577 | 4,368,804 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $62,910,777 | 4,368,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,291,203 | 4,693,389 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $39,208,636 | 4,775,717 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,282,677 | 4,794,780 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,063,649 | 4,794,780 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $51,326,541 | 4,892,902 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,466,683 | 4,569,802 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $95,901,284 | 4,551,556 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $67,504,385 | 3,760,690 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $42,368,731 | 2,574,042 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $40,511,254 | 2,026,576 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,026,109 | 1,640,725 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $43,398,452 | 1,913,512 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $50,671,913 | 1,917,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,515,176 | 2,004,663 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $65,614,074 | 1,976,923 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $62,039,192 | 1,897,223 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $84,175,401 | 2,008,001 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $83,069,108 | 2,138,201 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $79,828,076 | 2,340,313 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $96,321,597 | 2,123,492 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $61,319,128 | 2,228,166 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $82,380,091 | 2,236,766 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $75,719,529 | 2,338,466 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||